c e l l hexokinase a c t i v i t y i n v i t r o and t h a t the concentration of r e d c e l l 2.3-DPG may be influenced by serum P i i n vivo. Since the developing f e t a l lamb e x h i b i t s wide v a r i a t i o n i n i t s r e d c e l l 2.3-DPG content, hexokinase a c t i v i t y and serum P i were studied i n 7 lambs t h a t were followed s e q u e n t i a l l y from b i r t h u n t i l 8 weeks o f l i f e . The mean 2.3-DPG concentration on day 1 o f l i f e was 4389'994 mpmoles/ml RBC. There was a s i g n i f i c a n t increase@<0.00% i n 2.3-DPG from day 4 of life (mesn:8249'1754) through days 10-11 (mean:7577'1670) .
By day 17 o f l i f e the mean 2,3-DPG concentrat i o n decreased t o 4242'1832 mpmoles/ml RBC, and t h e r e a f t e r f e l l r a p i d l y ; by day 45 o f l i f e , 2.3-DPG was n o t detected. No meaaurable 2.3-DPG was found i n 6 a d u l t sheep. Red c e l l hexokinaae act i v i t y appeared t o be modulated by changes i n the 2.3-DPG c o n t e n t Hexokinase was 1.18'0.33 u n i t s / @ hemoglobin on day 1. f e l l t o 0.94'0.05 by days 10-11, and increased t o 1.16'0.13 on day 17. From days 1 through 60 o f l i f e , changes i n red c e l l 2.3-DPG cont e n t c o r r e l a t e d d i r e c t l y w i t h the serum P i ( r -0.82; p<0.001).
These data demonstrate an i n v i v o c o n f i r m a t i o n o f i n h i b i t i o n of r e d c e l l hexokinase a c t i v i t y by 2.3-DPG and the r e g u l a t i o n o f r e d c e l l 2.3-DPG concentration by serum P i i n the developing f e t a l lamb. I n prednlsone-dependent CHA, the l e v e l s o f o r o t a t e pllosphor l b o s y l transferase (OPRT) and o r o t l d i n e monophosphate decarboxylase ( O K ) were s i g n i f i c a n t l y elevated i n RBC. (OPRT: p a t i e n t s = 7.6-54.8 n m l e s / h r / l o 9 RBC; c o n t r o l s = 2.9 f 1.8 (Mean f S.O., n.30); OW: p a t i e n t s = 26-1 18 n m l e s / h r / l 0 9 ROC; c o n t r o l s = 10.6 f 4.7 (n=50)). I n I p a t i e n t p r i o r t o prednlsono therapy, the OPRT and ODC l e v e l s were 10-fold elevated and remained ) -f o l d elevated a f t e r one year o f therapy. I n 2 c l i n i c a l l y normal I n d i v i d u a l s , one o f whom was r e l a t e d t o a CHA p a t i e n t , the l e v e l s o f OPRT and ODC I n RBC were 1.6 t o 3.1 standard d e v i a t i o n s g r e a t e r than the mean of t h e c o n t r o l s . Elevated OPRT and O K d i d n o t occur i n leukocytes, f I b r o b l a s t s o r s h o r t term lymphocyte c u l t u r e s I n CIIA. The l e v e l s o f 3 o t h e r pyrlmldlne s y n t h e t i c enzymes, as w e l l as purlne and pyrimidine salvage enzymes, were w l t h i n normal l i m i t s I n a l l c e l l s studled. OPRT and O K a c t l v l t l e s wero a l s o elevated I n the RBC o f the f a t h e r of 2 s l b l l n q s (mother n o t tested), b u t were normal I n 3 parents of 2 o t h e r p a t i e n t s . I n c o n t r a s t t o CHA, a l l o f t h e pyrlmldlne b i o s y n t h e t i c enzymes i n c l u d i n q OPRT and OOC were elevated i n RBC o f s i c k l e c e l l anemla, OlGuglieimo syndrome and t h e newborn. I t I s postulated t h a t f a c t o r s which a f f e c t t h e Phosphofructokl nase (E) e x i s t s I n l sozyme forms I n various human t i s s u e s . Erythrocytes o f newborns have a r e l a t i v e PFK d e f i c i e n c y and an a l t e r e d r a t e o f g l y c o l y s l s . PFK I n the newborn a l s o shows increased I n -v l vo l a b i l l t y .
Experiments were deslgned t o e l ucidate t h e d l fferences between a d u l t and newborn e r y t h r o c y t e PFK. The p u r i f i e d enzymes from human muscle and l l v e r were separated by c h r~~a t o g r a p h y on DEAESephadex A-25 columns e q u i l i b r a t e d w l t h O.:Y Trls-PO4 pH 8.0, and e l u t i o n w l t h a s a l t gradient. Human muscle and I i v e r PFC e l u t e d as widely separated sharp peaks. A d u l t e r y t h r o c y t e PFK (from e i t h e r crude henalysates o r from p u r i f i e d preparat!ons) e l u t e d as a s i n g l e broad peak i n a p o s l t l o n intermediate between those o f t h e l i v e r and muscle lsozymes. Hemolysates f r m cord blood, examlned by t h l s technique, were found t o c o n s i s t o f two c l e a r l y separated PFK peaks: one chromatographical l y i n d i s t i n g u i s h a b l e from a d u l t e r y t h r o c y t e PFK, and a second peak chromatographically I n d l s t i n g u l s h a b l e from l i v e r PFK.
These data demonstrate t h a t i n f e t a l erythrocytes there I s an isozyme presumably I d e n t i c a l w l t h l i v e r PFK isozynle, which I s probably responsible f o r t h e r e l a t i v e d e f i c i e n c y o f PFK I n newborn erythrocytes. I n Cooley's snemia, maintenance o f a h e m g l o b i n l e v e l l Q . 5 g/dl prevents anoxia and suppresses endogenous erythropoiesls.
E i g h t p a t i e n t s have been ma!ntaired on t h i s t r a n s f u s i o n r e g i m r . since i n i t i a l diagnosis, f o r 3 t o 13 years. The paticln'r, have maint a i n e d excellertt h e a l t h and have been able t o l i v e n c r r a l l i v e s , i n c l u d i n g school sports. Hepato-splenomgaly has been c o n t a i r e d t o s modest level; hypersplenlsm has n o t develcped. Cardiac s i 7 e and f u n c t i o n have been normal; however, echo-cardiography revealed increased l e f t v e n t r i c u l a r w a l l t t i c k n e c ,~ i n c h i l d r e n o l d e r than 8 years, s u~g e s t i n g increased Fe depos'tion. PI1 c h i ldren have received t e s t doses o f I .M. 20 mg/Kg 15-16 times each year. The r e s u l t s i n d i c a t e t h a t I n the ycungest c h i ldren, 205 o f t h e transfused Fe, and i n t h e o l de s t c h l l d r e n , 502, could be e l i m i n a t e d by d a l l y I.rc. I n j e c t i o n s . Recently, the same dose o f Desferrloxamine-B has been adminlsterod by intravenous o r subcutaneous i n f u s i o n overnight. By these routes, t h e e x c r e t i o n o f Fe has lncreased f o u r f o l d I n the youngest, ard t w i c e I n +he o l d e s t c h i l d r e n .
Thus, c h i l d r e n w i t h Caoley's anemia may be kept I n e x c e l l e n t h e a l t h t,y t h l s t r a n s f u s i o n regimer,, and t h e i r o r overload prevented by d a i l y subcutaneous c h e l a t i o n therapy a t home. T h i s should r e s u l t i n Increased longevity.
ERYTHROCYTE MORPHOLOGY IN NEWBORN INFANTS.

A NEW LOOK. Alvin Zipursky, McMaster
University, Department of Pediatrics, Hamilton, Ontario, Canada.
We have developed a simple technique for the three dimensional assessment of glutaraldehyde fixed erythrocytes partially immobilized in glycerol. In 24 adults, 7 0 + 10% of erythroctes collected at room temperature were biconcave discs and 2 7 + 10% were bowl shaped or stomatocytes. In 36 newborn infants ( 2 7 premature and 9 full-term) significantly fewer We now sliow t h a t impaired microtubule assemhly a l s o c o r r e l a t e d n o t o n l y w i t h reduced chemotaxis and degranulation h u t w i t h decreascd granulocytc adherence (CAI as w e l l . GA was measured hy f i l t e r i n g p u r i f i e d P11Y over n y l o n f i h e r s contained i n a q s t e u r p i p e t t e and quantit a t i n g tile percentage o f PMN adhering t o the f i b e r s . GA i n normal mink and mice was 7 4 t l Z and 64%; whereas, i t was reduced i n C-11 mink and mice t o 40+_12 and 322 r e s p e c t i v e l y . Ilrugs prev i o u s l y shown t o i n i l l h i t microtubule assenbly i n P:M were examined. GA was decreascd t o 2726%. ?9+22 a~~d 19+L):! w i t h 10-5~1 colchicine. 5 d.1 diamide. 500 uP1 t e r t i a r y b u t y r y l l~y d r o p e r o x i d e r e s p e c t i v e l y i n human P:N compared t o nonnal values o f 43k22. When 5 uglml of cvtoclinlnsin D was incubated w i t h human P?W, a drug known t o i n h i b i t microfilament polymerization. CA was a l s o reduced t o 332.
These studies support the n o t i o n t h a t impairnent o f e i t h e r cytoplasmic microtuhule o r microfilnment assembly w i l l l e n d t o a l t e r a t i o n s i n the surfncc n r o p e r t t e n o f P'N memhrane which, i n turn, w i l l a f f e c t the a b i l i t y of the PW t o adhere t o a c t i v a t e d surfaces.
